Steve O'Loughlin
Director of Finance/CFO en ACTINIUM PHARMACEUTICALS, INC. .
Fortuna: 9 263 $ al 31/03/2024
Perfil
Steve O'Loughlin is currently the Chief Financial & Accounting Officer at Actinium Pharmaceuticals, Inc. Prior to this, he was the Vice President-Corporate Finance & Development at Protea Biosciences Group, Inc. from 2012 to 2015.
He completed his undergraduate degree at Ramapo College of New Jersey.
Participaciones conocidas en empresas públicas
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
| 28/12/2023 | 1 183 ( 0.00% ) | 9 263 $ | 31/03/2024 |
Cargos activos de Steve O'Loughlin
| Empresas | Cargo | Inicio |
|---|---|---|
| ACTINIUM PHARMACEUTICALS, INC. | Director of Finance/CFO | 15/05/2017 |
Antiguos cargos conocidos de Steve O'Loughlin.
| Empresas | Cargo | Fin |
|---|---|---|
| PROTEA BIOSCIENCES GROUP, INC | Corporate Officer/Principal | 01/06/2015 |
Formación de Steve O'Loughlin.
| Ramapo College of New Jersey | Undergraduate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 1 |
|---|---|
| ACTINIUM PHARMACEUTICALS, INC. | Health Technology |
| Empresas privadas | 1 |
|---|---|
Protea Biosciences Group, Inc.
 Protea Biosciences Group, Inc. Miscellaneous Commercial ServicesCommercial Services Protea Biosciences Group, Inc. engaged in the provision of molecular information services. It offers direct analysis, mapping, and display of biologically active molecules in living cells and tissue samples through its platform technology. The company was founded by Stephen C. Turner in July 2001 and was headquartered in Morgantown, WV. | Commercial Services |
- Bolsa de valores
- Insiders
- Steve O'Loughlin
